Clinical trial
China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis
NCT01763320 · Xuanwu Hospital, Beijing, Other · Completed
Key facts
| NCT number | NCT01763320 |
|---|---|
| Title | China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis |
| Official title | China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a New, Prospective, Multi-center, Randomized Controlled Trial in China |
| Acronym | CASSISS |
| Lead sponsor | Xuanwu Hospital, Beijing, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug, Procedure |
| Interventions | Intracranial stenting group, medical group |
| Enrollment | 380 |
| Start date | Mar 5, 2014 |
| Primary completion | Nov 10, 2016 |
| Completion | Nov 10, 2019 |
| First posted | Jan 8, 2013 |
| Last update posted | May 12, 2022 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: